Radiation schedule for prostate cancer PSA relapse after surgery
Part of Cancer, Injuries & trauma, Kidney & urinary clinical trials.
This trial compares two different radiation schedules to treat prostate cancer that returned based on rising PSA blood tests after prostatectomy (prostate removal). If you qualify, it may help you and your team choose a radiation approach with the goal of controlling PSA relapse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your prostate cancer was confirmed on pathology as intermediate- or high-risk
- Your PSA started rising again after prostate removal (PSA is >0.2 and ≤1.0 ng/mL, rising on repeat tests)
- You are able to do normal activities (ECOG 0–1)
- Your recent blood tests are strong enough: neutrophils (ANC) at least 1500, platelets at least 50,000, hemoglobin at least 8.0
- Your kidney and liver blood tests are within safe limits (creatinine <2.0; bilirubin <1.5× normal; liver enzymes <2.5× normal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing two types of radiation therapy for men whose PSA level rises after prostate removal, but without clear signs of cancer spread on a PSMA PET scan. The goal is to see which radiation schedule works better to control the cancer.
This trial studies a targeted, high-intensity radiation approach given after prostate removal surgery when prostate cancer seems to be coming back locally. It may help control the disease in the pelvis while avoiding treatment that could cause more side effects.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This trial compares two schedules of pelvic radiotherapy for men whose prostate cancer has returned after surgery. Both schedules aim to control the cancer with fewer visits for one of them.
This Phase 2 study compares two schedules of radiation treatment after prostate surgery in men whose PSA starts rising again. It aims to see which radiation approach works well while tracking quality of life and safety.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.